Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+CD25+ regulatory T cells

Transplantation

Volumn 82, Issue 12, 2006, Pages 1749-1755

  Xia, Guliang ^a   He, Jie ^a   Zhang, Zheng ^a   Leventhal, Joseph R ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Allograft; Ex vivo expansion; Natural CD4+CD25+; Rejection; Tolerance

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; CARDIAC GRAFT REJECTION; CD4+ CD25+ REGULATORY T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL SORTER; CELL SURVIVAL; CHRONIC GRAFT REJECTION; COCULTURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE MODEL; EFFECTOR CELL; EX VIVO STUDY; FEASIBILITY STUDY; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; LYMPHOID TISSUE; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SURVIVAL TIME; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; COCULTURE TECHNIQUES; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICROSPHERES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846010510     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250731.44913.ee     Document Type: Conference Paper

References (45)

1. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
2. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expression IL-2 receptor α-chain (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
3. + suppressor cell and its mechanisms of action. J Exp Med 1990; 171: 141.
4. + cells, and the alloreactive T cell clone size. J Immunol 2002; 169: 3744.
5. + T cells on the fate of allografts in the absence of immunosuppression. Transplantation 2005; 79: 648.
6. + T cells. J Immunol 2005; 174: 3741.
7. + regulatory T cell function in alloimmunity. J Immunol 2006; 176: 329.
8. + regulatory T cells in mouse hepatic allograft tolerance. Liver Transpl 2006; 12: 1112.
9. + T cells in human kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1643.
10. +T cells/ FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006; 81: 398.
11. + T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 2004; 77: 762.
12. + regulatory T cells in operational tolerance after living donor liver transplantation. Transplant Proc 2005; 37: 37.
13. Demirkiran A, Kok A, Kwekkeboom J, et al. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 12: 277.
14. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003; 88: 227.
15. Asiedu CK, Goodwin KJ, Balgansuren G, et al. Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin. J Immunol 2005; 175: 8060.
16. - regulatory cells mediate dominant transplantation tolerance. J Immunol 2002; 168: 5558.
17. + T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310.
18. + regulatory T cells from naïve host thymus in the induction of acquired transplant tolerance by immunization with allo-major histocompatibility complex peptide. Transplantation 2003; 75: 1136.
19. + regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
20. + precursors in a thymus-independent process. J Immunol 2004; 172: 923.
21. + T-cells into hepatic parenchyma in mice. J Med Invest 2004; 51: 178.
22. + T lymphocytes determines the outcome of tolerance across fully mismatched MHC barrier through linked recognition of self and allogeneic stimuli. J Immunol 2006; 176: 2324.
23. - T cells determines rejection or tolerance. Transpl Immunol 2006; 15: 311.
24. + regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 748.
25. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493.
26. + regulatory T cells. Int Immunol 2004; 16: 1189.
27. + regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA 2006; 103: 2758.
28. + regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. J Immunother 2006; 29: 336.
29. Masteller EL, Tang Q, Bluestone JA. Antigen-specific regulatory T cells- ex vivo expansion and therapeutic potential. Semin Immunol 2006; 18: 103.
30. + immunoregulatory T cells is antigen nonspecific. J Immunol 2000; 164: 183.
31. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
32. + T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004; 4: 65.
33. + T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 2004; 104: 3804.
34. + regulatory T cells protects from lethal acute GVHD. Blood 2005; 105: 2220.
35. + T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 2003; 9: 243.
36. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080.
37. Sawitzki B, Kingsley CI, Oliveira V, et al. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201: 1925.
38. + regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004; 172: 6539.
39. Sanchez-Fueyo A, Weber M, Domenig C, et al. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 2002; 168: 2274.
40. + regulatory T cells contributes to skin transplant tolerance. Transplantation 2003; 76: 1375.
41. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 2003; 100: 8886.
42. + regulatory T cells. J Immunol 2004; 172: 5240.
43. + T lymphocytes. Blood 2004; 103: 4216.
44. + regulatory T cells generated by exposure to a model protein antigen prevent allograft rejection: antigen-specific reactivation in vivo is critical for bystander regulation. Blood 2005; 105: 4871.
45. + regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. J Immunol 2005; 174: 3290.